{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T14:43:00Z","timestamp":1704724980293},"reference-count":59,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,3,15]],"date-time":"2004-03-15T00:00:00Z","timestamp":1079308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Little is known about the effect of 5\u2010hydroxytryptamine 1 (5\u2010HT<jats:sub>1<\/jats:sub>) receptor agonism on the co\u2010ordinated motor activity of the gastric antrum, pylorus and duodenum under fasting and fed conditions.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate the effect of sumatriptan, a 5\u2010HT<jats:sub>1<\/jats:sub> agonist, on fasting and fed antro\u2010pyloro\u2010duodenal motility.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002In study 1, antro\u2010pyloro\u2010duodenal motility was recorded for two phase IIIs of the migrating motor complex and then, following either a subcutaneous injection of sumatriptan 6\u2003mg or saline control, for at least one additional phase III in 11 healthy volunteers (21\u201336\u2003years). In study 2, the post\u2010prandial motility was recorded for 3\u2003h after either a subcutaneous injection of sumatriptan 6\u2003mg or saline control in 10 healthy volunteers (18\u201336\u2003years).<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Sumatriptan prolonged the migrating motor complex cycle (<jats:italic>P\u2003=<\/jats:italic>\u20030.009) by increasing the duration of phase II (<jats:italic>P\u2003=<\/jats:italic>\u20030.02) but not phases I and III. Post\u2010prandially, sumatriptan reduced the activity index (<jats:italic>P\u2003=<\/jats:italic>\u20030.017) by reducing the frequency of co\u2010ordinated motor activity involving the antrum and\/or the duodenum (<jats:italic>P\u2003&lt;<\/jats:italic>\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u20025\u2010HT<jats:sub>1<\/jats:sub> receptor agonism increases the periodicity of the migrating motor complex and reduces the occurrence of post\u2010prandial co\u2010ordinated motor activity involving the gastric antrum, pylorus and duodenum.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.01901.x","type":"journal-article","created":{"date-parts":[[2004,3,23]],"date-time":"2004-03-23T14:09:27Z","timestamp":1080050967000},"page":"805-815","source":"Crossref","is-referenced-by-count":10,"title":["Inter\u2010digestive and post\u2010prandial antro\u2010pyloro\u2010duodenal motor activity in humans: effect of 5\u2010hydroxytryptamine 1 receptor agonism"],"prefix":"10.1111","volume":"19","author":[{"given":"E. L.","family":"Calvert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Whorwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,3,18]]},"reference":[{"key":"e_1_2_16_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.1996.tb00270.x"},{"key":"e_1_2_16_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001574-200103000-00001"},{"key":"e_1_2_16_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.suppl_1.i77"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.1.42"},{"key":"e_1_2_16_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.663"},{"issue":"4","key":"e_1_2_16_7_2","first-page":"304","article-title":"Evidence for increased plasma 5\u2010hydroxytryptamine (5\u2010HT) concentration following meal ingestion in patients with functional dyspepsia (FD) and its relationship to gender and symptoms","volume":"122","author":"Lea R","year":"2002","journal-title":"Gastroenterology"},{"key":"e_1_2_16_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01094.x"},{"key":"e_1_2_16_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.671"},{"key":"e_1_2_16_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01449.x"},{"key":"e_1_2_16_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01103.x"},{"key":"e_1_2_16_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70251-4"},{"issue":"4","key":"e_1_2_16_13_2","first-page":"154","article-title":"A phase II placebo controlled randomised trial with tegaserod (T) in functional dyspepsia (FD) patients with normal gastric emptying (NGE)","volume":"122","author":"Tack J","year":"2002","journal-title":"Gastroenterology"},{"key":"e_1_2_16_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00610.x"},{"key":"e_1_2_16_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00375.x"},{"key":"e_1_2_16_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04138.x"},{"key":"e_1_2_16_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00762.x"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00941.x"},{"key":"e_1_2_16_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01144.x"},{"key":"e_1_2_16_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70012-5"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00732.x"},{"key":"e_1_2_16_22_2","first-page":"G902","article-title":"Sumatriptan, a selective 5\u2010HT1\u2010receptor agonist, induces a lag phase for the emptying of liquids in humans","volume":"272","author":"Coulie B","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_16_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1999.276.2.G373"},{"key":"e_1_2_16_24_2","first-page":"359","volume-title":"Gastroenterology Clinics of North America, 18(No. 2).","author":"Read NW","year":"1989"},{"key":"e_1_2_16_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05421.x"},{"key":"e_1_2_16_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.1.36"},{"key":"e_1_2_16_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90664-6"},{"key":"e_1_2_16_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90665-8"},{"key":"e_1_2_16_29_2","first-page":"384","article-title":"Electrical activity, motility and acid secretion of the human stomach","volume":"57","author":"Kwong NK","year":"1970","journal-title":"Br J Surg"},{"key":"e_1_2_16_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02231736"},{"key":"e_1_2_16_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.10.1349"},{"key":"e_1_2_16_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.1990.tb00026.x"},{"key":"e_1_2_16_33_2","first-page":"G671","article-title":"Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers","volume":"254","author":"Heddle R","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_16_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90328-X"},{"key":"e_1_2_16_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(83)90252-5"},{"key":"e_1_2_16_36_2","first-page":"72","article-title":"Dose\u2010related effect of erythromycin on gastroduodenal motility and plasma motilin levels. Studies in healthy volunteers and in patients with diabetic gastroparesis","volume":"103","author":"Tack J","year":"1991","journal-title":"Gastroenterology"},{"key":"e_1_2_16_37_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0016-5085(83)80233-9","article-title":"Stress\u2010induced gastrointestinal motor disturbances in humans: possible humoral mechanisms","volume":"85","author":"Stanghellini V","year":"1983","journal-title":"Gastroenterology"},{"key":"e_1_2_16_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.5.643"},{"key":"e_1_2_16_39_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1985.249.5.G580"},{"key":"e_1_2_16_40_2","first-page":"233","volume-title":"Motility of the Digestive Tract","author":"Jacobs F","year":"1982"},{"key":"e_1_2_16_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.4.466"},{"key":"e_1_2_16_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1989.tb01741.x"},{"key":"e_1_2_16_43_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1995.sp020957"},{"key":"e_1_2_16_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02300360"},{"key":"e_1_2_16_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90058-2"},{"key":"e_1_2_16_46_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1998.275.5.G1173"},{"key":"e_1_2_16_47_2","first-page":"285","article-title":"The pharmacology of sumatriptan","volume":"5","author":"Beattie DT","year":"1994","journal-title":"Rev Contemp Pharmacother"},{"key":"e_1_2_16_48_2","doi-asserted-by":"crossref","first-page":"iv20","DOI":"10.1136\/gut.47.suppl_4.iv20","article-title":"Receptors of the enteric nervous system: potential targets for drug therapy","volume":"47","author":"Tack J","year":"2000","journal-title":"Gut"},{"key":"e_1_2_16_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(90)90061-U"},{"key":"e_1_2_16_50_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243050-00010"},{"key":"e_1_2_16_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.1.72"},{"key":"e_1_2_16_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1996.tb02149.x"},{"key":"e_1_2_16_53_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00280.2002"},{"key":"e_1_2_16_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.12.2094"},{"key":"e_1_2_16_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91642-X"},{"key":"e_1_2_16_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00518.x"},{"key":"e_1_2_16_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01509.x"},{"key":"e_1_2_16_58_2","first-page":"A64(Abstract","article-title":"Sumatriptan, a 5\u2010HT1 agonist, increases gastroesophageal reflux","volume":"42","author":"Foster JM","year":"1998","journal-title":"Gut"},{"key":"e_1_2_16_59_2","first-page":"A733(Abstract","article-title":"Further evidence that sumatriptan induced chest pain is oesophageal in origin: effect of oesophageal visceral sensation","volume":"112","author":"Foster JM","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_16_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90993-Q"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01901.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01901.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.01901.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:10:28Z","timestamp":1697227828000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.01901.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,18]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1111\/j.1365-2036.2004.01901.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01901.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,18]]}}}